GERARD A SILVESTRI

Papers

2

Total Citations

5

H-Index

1

About

Dr. Gerard A. Silvestri is a leading pulmonologist and researcher whose work centers on advancing the diagnosis and management of lung cancer through innovative bronchoscopic technologies. His major contributions include spearheading the landmark TARGET trial, a prospective, multicenter evaluation that established the safety and diagnostic efficacy of robotic-assisted bronchoscopy for peripheral pulmonary lesions. This work, published in 2024, has already garnered significant attention with 4 citations, underscoring its immediate impact on clinical practice. Dr. Silvestri’s research also encompasses real-world evidence from the TARGET study, demonstrating the practical safety outcomes of robotic bronchoscopy in diverse clinical settings. With a career dedicated to improving early detection and minimally invasive diagnostic techniques, his findings have shaped guidelines and inspired further innovation in interventional pulmonology. His achievements include leadership in multicenter trials that bridge the gap between cutting-edge technology and patient-centered care, making him a pivotal figure in respiratory medicine. For students and researchers, Dr. Silvestri’s work exemplifies how rigorous clinical investigation can transform lung cancer diagnostics and improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A PROSPECTIVE, MULTICENTER EVALUATION OF SAFETY AND DIAGNOSTIC OUTCOMES WITH ROBOTIC-ASSISTED BRONCHOSCOPY: RESULTS FROM THE TARGET TRIAL
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago